<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0001945'>Fever</z:hpo> of unknown origin is a diagnostic challenge in children, especially for differentiation of systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> juvenile idiopathic <z:hpo ids='HP_0001369'>arthritis</z:hpo> (systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e>) and <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We undertook this study to analyze the relevance of myeloid-related proteins (MRPs) 8 and 14, endogenous activators of Toll-like receptor 4, in diagnosis and pathogenesis of systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Serum concentrations of MRP-8/MRP-14 were analyzed in 60 patients with systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e>, 85 patients with <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infections</z:e>, 40 patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, 5 patients with <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo>, 18 patients with <z:hpo ids='HP_0003623'>neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>), and 50 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we investigated the link between interleukin-1beta (IL-1beta) and MRP-8/MRP-14 in systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Serum MRP-8/MRP-14 concentrations were significantly (P &lt; 0.001) elevated in patients with active systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> (mean +/- 95% confidence interval 14,920 +/- 4,030 ng/ml) compared with those in healthy controls (340 +/- 70 ng/ml), patients with <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infections</z:e> (2,640 +/- 720 ng/ml), patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (650 +/- 280 ng/ml), patients with <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (840 +/- 940 ng/ml), and patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> (2,830 +/- 580 ng/ml) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast to C-reactive protein levels, MRP-8/MRP-14 concentrations distinguished systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> from <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, with a specificity of 95% </plain></SENT>
<SENT sid="6" pm="."><plain>MRP-14 in serum of patients with systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> was a strong inducer of IL-1beta expression in phagocytes </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The analysis of MRP-8/MRP-14 in serum is an excellent tool for the diagnosis of systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e>, allowing early differentiation between patients with systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> and those with other <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>MRP-8/MRP-14 and IL-1beta represent a novel positive feedback mechanism activating phagocytes via 2 major signaling pathways of innate immunity during the pathogenesis of systemic-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> </plain></SENT>
</text></document>